Study Scavenger Clinical Trial Platform ICON Early Phase Services is conducting a research study for healthy males & females ages 18-55 Study for healthy non-smoking adults at ICON with compensation up to $29,925 for participation. Even if you do not qualify, you...
Study Scavenger Clinical Trial Platform ICON Early Phase Services is conducting a research study for healthy males & females ages 18-50 in San Antonio, TX The Investigational drug is being developed as a possible treatment of breast cancer. Phase: I Health...
Real-world evidence (RWE) or real-world data (RWD) relates to the collection of information about a drug’s safety and efficacy outside the structure of a clinical trial. Speaking yesterday at the Bipartisan Policy Center conference, U.S. Food and Drug Administration...
CD8+ T Cell agent could be used for early prediction of therapeutic response in metastatic cancer patients ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell imaging agent. The trial will enroll...
80% of Treated Patients with Clinical Response at 48 weeks, Published in Gastroenterology Cytori Therapeutics, Inc. (NASDAQ: CYTX) announces the publication of results from a pilot investigator-initiated clinical trial of Cytori Cell Therapy™ for the treatment of...
Email
Text